Kymriah (tisagenlecleucel) made history in August 2017 when it became the world’s first approved chimeric antigen receptor (CAR) T-cell therapy,...
Read More...
The post The world’s first CAR-T therapy has been approved for a second indication appeared first on Pharmaceutical Technology.